Unfurl the sails and batten down the hatches as we embark on a thrilling voyage across the tumultuous seas of the stock market ocean. The Zacks Rank #1 (Strong Buy) List has unveiled its latest treasures — five wondrous stocks that have captured the market’s imagination. Let’s navigate the turbulent tides and examine what sets these stocks apart.
ADMA Biologics, Inc.
Charting its course through the biopharmaceutical waters, ADMA Biologics, Inc. has witnessed its Zacks Consensus Estimate for current year earnings surge by a remarkable 33.3% over the past 60 days.
Arcutis Biotherapeutics, Inc.
Slicing through the competitive currents, Arcutis Biotherapeutics, Inc. has navigated a 10.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Phreesia, Inc.
Venturing into the realm of SaaS-based software and payment platforms for the healthcare industry, Phreesia, Inc. has witnessed an 11.1% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
OptimizeRx Corporation
Innovating in the digital health technology sector, OptimizeRx Corporation has soared with a 25% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Koninklijke Philips N.V.
Guiding the course in the health technology sector, Koninklijke Philips N.V. has seen a 4.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
You can uncover the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Reveals ChatGPT “Sleeper” Stock
Embark on a compelling exploration into an obscure company blazing a trail in the burgeoning Artificial Intelligence sector. By 2030, the AI industry is forecasted to wield an economic impact equivalent to the internet and the iPhone combined, amounting to a staggering $15.7 trillion.
For intrepid readers, Zacks unveils a bonus report spotlighting this explosive growth stock and four other indispensable recommendations. Plus more. Snatch the Free ChatGPT Stock Report right now >>
Koninklijke Philips N.V. (PHG) : Free Stock Analysis Report
OptimizeRx Corp. (OPRX) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Phreesia, Inc. (PHR) : Free Stock Analysis Report
Arcutis Biotherapeutics, Inc. (ARQT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Remember, the opinions expressed herein are the author’s alone and do not reflect those of Nasdaq, Inc.
